Maraviroc and Non-hodgkin's lymphoma - a phase IV clinical study of FDA data

Summary:

Non-hodgkin's lymphoma is reported as a side effect among people who take Maraviroc (maraviroc), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Darunavir, and have Hiv infection.

The phase IV clinical study analyzes which people have Non-hodgkin's lymphoma when taking Maraviroc. It is created by eHealthMe based on reports of 2,652 people who have side effects when taking Maraviroc from the FDA, and is updated regularly.

What is Maraviroc?

Maraviroc has active ingredients of maraviroc. eHealthMe is studying from 2,653 Maraviroc users. Check the latest studies of Maraviroc.

What is Non-hodgkin's lymphoma?

Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system) is found to be associated with 718 drugs and 1,408 conditions by eHealthMe. Check the latest studies of Non-hodgkin's lymphoma.

On Aug, 02, 2026

2,652 people reported to have side effects when taking Maraviroc.
Among them, 20 people (0.75%) have Non-hodgkin's lymphoma.

Could Maraviroc cause Non-hodgkin's lymphoma?

Among these 20 people:

How long have people been on Maraviroc when they have Non-hodgkin's lymphoma? *

What is the gender of people who have Non-hodgkin's lymphoma when taking Maraviroc? *

female: 5.56 %
male: 94.44 %

What is the age of people who have Non-hodgkin's lymphoma when taking Maraviroc? *

What are other drugs people take besides Maraviroc? *

What are other side effects people have besides Non-hodgkin's lymphoma? *

Haemolytic Anaemia (anaemia due to haemolysis): 5 people, 25.00%
Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 1 person, 5.00%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 5.00%
Back Pain: 1 person, 5.00%
Blood Creatinine Increased: 1 person, 5.00%
Blood Hiv Rna Increased: 1 person, 5.00%
Bullous Lung Disease: 1 person, 5.00%
Chlamydial Infection (a common sexually transmitted infection (sti) in humans caused by the bacterium chlamydia trachomatis): 1 person, 5.00%
Drug Ineffective: 1 person, 5.00%
Eye Infection Syphilitic (ocular syphilis is a form of the sexually transmitted disease affecting eyes): 1 person, 5.00%

What are the existing conditions these people have? *

Hiv Infection: 16 people, 80.00%
Pain: 2 people, 10.00%
Itching: 2 people, 10.00%
Insomnia (sleeplessness): 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Dyspnea (difficult or laboured breathing): 2 people, 10.00%
Constipation: 2 people, 10.00%
Nausea (feeling of having an urge to vomit): 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%
Discomfort: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Maraviroc and have Non-hodgkin's lymphoma?

- Check whether Non-hodgkin's lymphoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maraviroc:

Maraviroc (2,653 reports)

Browse all side effects of Maraviroc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Non-hodgkin's lymphoma:

Non-hodgkin's lymphoma (718 drugs)

Browse all the conditions that are associated with Non-hodgkin's lymphoma:

Non-hodgkin's lymphoma (1,408 conditions)

Related publications that referenced our studies

Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on maraviroc (the active ingredients of Maraviroc) and Maraviroc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.